Takeda Pharmaceutical Company Stocks List

Recent Signals

Date Stock Signal Type
2021-03-05 ALNY Crossed Above 200 DMA Bullish
2021-03-05 ALNY Bullish Engulfing Bullish
2021-03-05 ALNY Lower Bollinger Band Walk Weakness
2021-03-05 AMGN Stochastic Buy Signal Bullish
2021-03-05 AMGN Lower Bollinger Band Walk Weakness
2021-03-05 AMGN Slingshot Bearish Bearish Swing Setup
2021-03-05 CRDF Pocket Pivot Bullish Swing Setup
2021-03-05 CRDF Hammer Candlestick Bullish
2021-03-05 GOSS Lower Bollinger Band Walk Weakness
2021-03-05 ITCI Crossed Above 50 DMA Bullish
2021-03-05 ITCI Lower Bollinger Band Walk Weakness
2021-03-05 ITCI MACD Bearish Centerline Cross Bearish
2021-03-05 LXRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 LXRX Doji - Bullish? Reversal
2021-03-05 LXRX Hammer Candlestick Bullish
2021-03-05 LXRX 50 DMA Support Bullish
2021-03-05 LXRX Lower Bollinger Band Walk Weakness
2021-03-05 LXRX MACD Bearish Centerline Cross Bearish
2021-03-05 LXRX Lizard Bullish Bullish Day Trade Setup
2021-03-05 OVID Calm After Storm Range Contraction
2021-03-05 TAK 20 DMA Support Bullish
2021-03-05 TYME Doji - Bullish? Reversal
2021-03-05 TYME Lizard Bullish Bullish Day Trade Setup
2021-03-05 TYME New Downtrend Bearish

Recent News for Takeda Pharmaceutical Company Stocks

Date Stock Title
Mar 6 LXRX The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 6 AMGN SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Five Prime Therapeutics, Inc. (Nasdaq - FPRX)
Mar 5 AMGN Amgen: 10-12% Upside Going Into March
Mar 5 TAK Senate Democrats Agree to Lower Unemployment Benefits in Aid Bill
Mar 5 AMGN Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout
Mar 5 AMGN ETFs to Tap Amgen's Drive for Cancer Deal
Mar 5 TAK The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Mar 5 TAK Moderna, via Takeda, seeks authorization for COVID-19 vaccine in Japan
Mar 5 TAK Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan
Mar 5 AMGN Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79%
Mar 5 TAK Takeda files to import Moderna’s COVID-19 vaccine in Japan
Mar 5 TAK UPDATE 2-Drugmaker Takeda asks Japan for Moderna COVID-19 shot approval
Mar 5 AMGN Amgen Inc. (AMGN) Management Presents at Cowen 41st Annual Healthcare Conference (Transcript)
Mar 4 AMGN Amgen Acquires a Cancer Drug. Expect More Deals.
Mar 4 AMGN Amgen: One Of The Few Bargains In This Market
Mar 4 LXRX Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Mar 4 AMGN SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
Mar 4 TYME Tyme: Undercovered Growth Story In Pancreatic Cancer
Mar 4 AMGN Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
Mar 4 LXRX Will Lexicon Pharmaceuticals (LXRX) Report Negative Q4 Earnings? What You Should Know

The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

More about Takeda Pharmaceutical Company
Browse All Tags